(marketscreener.com) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 ...https://www.marketscreener.com/quote/stock/F-STAR-THERAPEUTICS-INC-115594552/news/F-star-Therapeutics-Acquisition-Asset-Disposal-Form-8-K-43202979/?utm_medium=RSS&utm_content=20230309
F-star is an England-based biotechnology company that develops and commercializes novel antibody therapies for the treatment of cancer and orphan diseases.